Episodes
Thursday Apr 29, 2021
Is Home Blood Pressure Monitoring a “Home Run” for Blood Pressure Management?
Thursday Apr 29, 2021
Thursday Apr 29, 2021
Nearly 67 million people, which equates to 3 out of every 4 people, living with high blood pressure in the US remain uncontrolled, despite the clear and compelling benefits of achieving good control. Remote monitoring and self-management of BP may enable us to broadly achieve optimal BP control in most patients. Increased use of telehealth technology improves access to care, but the effects on the cost and quality of care, particularly in the context of hypertension management, have not been clearly established.
Guest Authors: Mary Taylor, PharmD and Megan Supple, PharmD, BCACP, CPP
Guest Panelist: Joseph Saseen, PharmD, BCPS, BCACP, CLS
Music by Good Talk
Friday Apr 16, 2021
Increasing the Patient-Clinician Connection: the “Presence 5 Practices”
Friday Apr 16, 2021
Friday Apr 16, 2021
Amidst scientific and technological advancements and an increasing focus on administrative tasks and metrics, meaningful connections with patients are falling by the wayside. Mindlessly using technology can be distracting and lower patient perceptions of their quality of care. How can the busy practitioner increase “presence” with patients while still meeting clinical and administrative demands?
Guest Authors: Emily Prohaska, PharmD, BCACP, BCGP and Nick Schulte, PharmD, BCPS
Music by Good Talk
Friday Jan 15, 2021
Closing the Loop for Children with Type 1 Diabetes
Friday Jan 15, 2021
Friday Jan 15, 2021
Insulin pumps and continuous glucose monitors (CGM) have changed the standard of care for managing Type 1 Diabetes. A closed-loop system (also described as an artificial pancreas or automated insulin delivery system) consists of a CGM, an insulin pump, and a control algorithm that automatically calculates basal insulin delivery based on real-time glucose levels. Closed-loop insulin pumps may offer an opportunity to improve glycemic management while reducing some of the associated stress. However, there are limited data evaluating the safety and efficacy of this technology in children less than 14 years old.
Guest Authors: Mary K Culp, PharmD and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES
Music by Good Talk
Friday Nov 13, 2020
Using shared decision-making tools: Are they worth it?
Friday Nov 13, 2020
Friday Nov 13, 2020
There’s no denying that shared decision making (SDM) is an effective communication approach for making patient-centered medical decisions across a variety of health conditions. However, while tools for SDM are often useful during patient visits with practitioners, studies have yielded mixed results with regard to patient outcomes. A new study explores the impact of a SDM tool for anticoagulation selection in patients with atrial fibrillation compared to standard care.
Guest Authors: Ashley Meredith, PharmD, BCACP, BCPS, CDCES and Chandler Howell, PharmD
Music by Good Talk
Friday Jul 17, 2020
Powerful Placebos and Notorious Nocebos: Implications for Ambulatory Care
Friday Jul 17, 2020
Friday Jul 17, 2020
Imagine you have recommended statin therapy to a patient with diabetes. A few weeks later, the patient experiences leg pain and stops it. Was this patient’s leg pain caused by the statin? Or was it a nocebo effect? Muscle symptoms in placebo-controlled trials of statin therapy range from 3-5%, while rates in real-world observational studies are between 15-20%. Ambulatory care pharmacists have an important role in recognizing and managing placebo and nocebo effects. Understanding the placebo effect allows clinicians to harness the power of placebos. Reframing risks during patient education may decrease nocebo effects.
Guest Authors: Sara Wettergreen, PharmD, BCACP and Joseph Nardolillo, PharmD
Music by Good Talk
Friday Apr 10, 2020
A CLEAN Sweep: Getting Rid of the Medication Cost Barrier
Friday Apr 10, 2020
Friday Apr 10, 2020
Medication adherence plays a very significant role in achieving positive patient health outcomes and when medication regimens are not followed, patients often fail to reach optimal disease control. This is especially concerning in ambulatory care settings where chronic disease states are most often treated. One of the potential barriers to optimal medication use is cost.
Guest Authors: Emily Eddy, PharmD, BCACP, BC-ADM; Brittany Long, PharmD, BCACP; and Lindsey Petters, PharmD, BCPS
Music by Good Talk
Saturday Feb 29, 2020
Don’t Let Numbers Fool You: Levothyroxine Isn’t a Cure-all
Saturday Feb 29, 2020
Saturday Feb 29, 2020
Patients with subclinical hypothyroidism often complain of symptoms commonly seen in patients with overt hypothyroidism: cold insensitivity, dry skin, fatigue, constipation, muscle cramps, poor memory, slowed thinking, and depression. Indeed, up to a quarter of people with normal TSH levels report up to two of these symptoms, pointing to the non-specific nature of these symptoms. How then should a clinician decide which patients might benefit from thyroid replacement therapy?
Guest Authors: Mallory Kuchis, PharmD and Michael P. Kane, PharmD, BCPS, BCACP
Music by Good Talk
Friday Jan 31, 2020
Friday Jan 31, 2020
One in six patients with atrial fibrillation (AF), or an estimated six million patients worldwide, will require perioperative anticoagulant management this year. Ambulatory care pharmacists commonly face the scenario where a patient taking a direct oral anticoagulant (DOAC) for AF requires an elective surgery or procedure. Best practices for periprocedural management of DOACs are unclear and current guidelines differ in their recommended approaches. Having a simple, systematic periprocedural DOAC management protocol would be helpful. But would a straightforward protocol that is easily understood by clinicians and patients be safe and effective? The PAUSE study investigators attempt to establish the standard of care.
Guest Authors: Maggie Faraj, PharmD and Candice Garwood, PharmD, BCPS, BCACP
Music by Good Talk
Friday Nov 08, 2019
Friday Nov 08, 2019
Treatment-resistant hypertension, the need for 4 or more medications to achieve goal blood pressure (BP), occurs in nearly 1 in 5 patients.1 But is it truly treatment-resistant? Nonadherence is often regarded as the primary cause in many patients. But how can we distinguish between other causes of hypertension that should prompt additional diagnostic testing or treatment intensification? A recent study suggests there is a simple solution: watch them take their pills.
Guest Authors: Meagan Brown, PharmD, BCACP and Raven Jackson, PharmD
Music by Good Talk
Friday Aug 30, 2019
Addressing the Concerns and Needs of Transgender Persons
Friday Aug 30, 2019
Friday Aug 30, 2019
The transgender/gender nonconforming (TGNC) community faces a variety of challenges including access to healthcare, societal stigma, and discrimination. As a profession, pharmacy is well-positioned to reduce and address the barriers to care faced by TGNC individuals and to provide them with positive experiences within the healthcare system. However, formal instruction about this patient population’s social and medical needs is lacking in most pharmacy school curricula.
Guest Authors: Justin Bachman, PharmD and Abby Frye, PharmD, BCACP
Music by Good Talk